Why Novo Nordisk Stock Popped Today [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
10 stocks we like better than Novo Nordisk › Shares of Novo Nordisk (NYSE: NVO) rose more than 7% on Tuesday after the drugmaker received regulatory approval for its long-awaited GLP-1 pill in the U.S. The U.S. Food and Drug Administration (FDA) approved the Danish healthcare leader's once-daily oral semaglutide treatment to reduce excess body weight and maintain weight reduction in adults. The pill, which will be marketed under the brand name Wegovy, showed a mean weight loss of 16.6% in a clinical trial. That's similar to results achieved with the company's injectable Wegovy treatment, and with a comparable safety profile. "As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy pill provides patients with a new, convenient treatment option that can help patients start or continue their weight loss journey," CEO Mike Doustdar said in a press release. Novo Nordisk intends to launch its Wegovy pill in the U.S. in early January. The pharm
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lilly, Novo lock horns in India's obesity drug race [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk gets landmark obesity pill approved, with production ‘underway' in NC [Yahoo! Finance]Yahoo! Finance
- Stock Market Today, Dec. 23: U.S. Stocks Hold Near Records on Narrow Tech-Led Gains [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk says FDA approved Wegovy pill to reduce body weight [Yahoo! Finance]Yahoo! Finance
- Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez [CNBC]CNBC
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website